Low HDL predicts differential blood pressure effects from two weight-loss approaches: A secondary analysis of blood pressure from a randomized, clinical weight-loss trial

Diabetes, Obesity and Metabolism

Volumn 14, Issue 4, 2012, Pages 375-378

  Turer, C B ^a   Bernstein, I H ^a   Edelman, D E ^b,c   Yancy, W S ^b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical trial; Dietary intervention; Dyslipidaemia; Hypertension; Obesity therapy; Weight loss therapy

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TETRAHYDROLIPSTATIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET; FEMALE; HUMAN; LABORATORY TEST; LOW CARBOHYDRATE DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL HISTORY; OBESITY; PREDICTION; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

EID: 84858009320     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01531.x     Document Type: Article

References (11)

1. Brunner E, Rees K, Ward K, Burke M, Thorogood M. Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev 2007; 4: CD002128.
2. Yancy WS, Westman EC, McDuffie JR et al. A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss. Arch Intern Med 2010; 170: 136-145.
3. NIH; NHLBI NAASO. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Rockville, MD: National Institutes of Health, 2000, NIH Publication No. 00-4084.
4. Chobanian AV, Bakris GL, Black HR et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC7 Report. JAMA 2003; 289: 2560-2572.
5. Kannel WB, Sorlie P. Some health benefits of physical activity: the Framingham Study. Arch Intern Med 1979; 139: 857-861.
6. Alberti KGMM, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
7. Razminia M, Trivedi A, Molnar J et al. Validation of a new formula for mean arterial pressure calculation: the new formula is superior to the standard formula. Catheter Cardiovasc Interv 2004; 63: 419-425.
8. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002; 59: 877-883.
9. Lowenstein CJ, Cameron SJ. High-density lipoprotein metabolism and endothelial function. Curr Opin Endocrinol Diabetes Obes 2010; 17: 166-170.
10. Bisoendial RJ, Hovingh GK, Levels JH et al. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 2003; 107: 2944-2948.
11. McClelland GH, Judd CM. Statistical difficulties of detecting interactions and moderator effects. Psychol Bull 1993; 114: 376-390.